Investor Relations

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Iris BioTechnologies Inc.'s financial performance into perspective.

Frost & Sullivan Recognizes Iris BioTechnologies for Technology Innovation.
Click here to read press release.

Recent Releases

Jan 21, 2009
Iris BioTechnologies Launches "Health Passport" in Its BioWindows(TM) 2.0 Informatics System for Personalized and Targeted Medicine

Sep 16, 2008
Iris BioTechnologies Chairman & CEO Simon Chin Gave Acceptance Speech for Frost & Sullivan's 2008 North America Technology Innovation Award in Pharmacogenomics

View all releases »

Stock Information

BB:IRSB
$0.62 - 0.01

Mar 5, 2010
3:52 PM ET

Quotes delayed at least 20 minutes. Information provided by eSignal.